Dietary energy restriction tested to reverse prediabetes – study withdrawn
NCT ID NCT06451055
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study aimed to see if an 8-week low-calorie diet (about 1,300 calories per day) could reverse isolated impaired fasting glucose, a form of prediabetes, in overweight adults aged 35 to 65. Participants would have received pre-prepared meals and been monitored for changes in blood sugar and weight. However, the study was withdrawn before enrolling anyone, so no data are available.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Low-calorie diet (approximately 1,300 kcal/day)
What this could lead to
If it works, this could point toward a simple dietary approach to reverse early prediabetes without medication.
What could go wrong
The study was withdrawn before any participants enrolled, so no results are available. Dietary interventions can be hard to stick with long-term, and effects may not last.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ISOLATED IMPAIRED FASTING GLUCOSE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Georgia Clinical & Translational Science Alliance (CTSA) Clinical Research Centers (GCRCs)
Atlanta, Georgia, 30322, United States